Ignacio Visus

Enhorabuena @Mamen_RubioR por haber salido elegida presidenta electa de @ESTRO_RT

You'll recognize a few names on this author list! @AgrawalAmiya @CJTsaiMDPhD & team show us that palliative RT is undergoing a major evolution ⚡️—from symptom relief ➡️ a multidisciplinary, precision-driven discipline with a dedicated workflow! What’s changing? 🧠 Team-based care is central: #radonc + physicists + advanced practice RTTs + NPs + supportive care = more personalized, efficient & safer treatment decisions ⏱️ Rapid-access clinics ✔️ Referrals seen within ~24 hrs ✔️ “One-stop” visits: consult + simulation same day ✔️ Fast-track pathways deliver RT within hours for pain crises 🚀 Workflow innovation ✔️ Simulation-free RT using recent diagnostic CTs ✔️ Single-fraction treatments (8–20 Gy) ✔️ Fewer hospital visits + faster symptom relief 🎯 Better technology = better care ✔️ IMRT/VMAT + SBRT improve conformality ✔️ Reduce toxicity to normal tissues ✔️ Enable safer re-irradiation & hypofractionation 👩‍⚕️ Advanced providers expand capacity ✔️ pAPRTs: contouring, planning, workflow leadership ✔️ NPs: toxicity management, follow-up, continuity ✔️ Earlier detection of complications + improved experience 🔬 Not just care—innovation hub ✔️ Trials reducing skeletal events with prophylactic RT ✔️ Survival gains (e.g., proton CSI in leptomeningeal disease) 🚨Bottom line: Palliative RT is no longer just supportive care—it’s fast, adaptive, multidisciplinary, and increasingly impactful on outcomes and quality of life 💡 @ASTRO_org advancesradonc.org/article/S2452-…

📊 How much do governments spend, and what do they spend it on? In the chart, we see total government spending broken down by purpose, such as health, education, and defense, relative to the size of the economy (as measured by GDP). This is shown for a selection of OECD countries. How much governments spend varies quite a lot across OECD countries: in France it’s 57% of GDP, while in Chile it’s less than half that (28%). Keep in mind that these are relative shares, not absolute amounts. GDP itself varies considerably across countries, so the same percentage can represent very different sums depending on the size of a country’s economy. For some categories, such as social protection — which includes things like pensions, unemployment benefits, disability support, and other benefits — the difference across countries is relatively large. For example, it’s 26% in Finland compared to 7.9% in the US. In other categories, such as public services — which include things like paying interest on government debt, the running of core government functions, and foreign aid — the share is more similar across countries. This data comes from the OECD’s Government at a Glance dataset, which covers 47 countries. Our colleague @parriagadap recently updated our charts with the latest release.

Quizá el mejor vídeo del lanzamiento de Artemisa II

Can salvage #brachytherapy cure recurrent #prostatecancer? The new RESPRO study shows it can, with a 93.6% rate of 10-year overall survival! 💡 A major step forward for real-world evidence in #radonc. 👉 Read the full interview with co-authors: bit.ly/4mdNXxK

@drjavierserrano presidente de @SEOR_ESP ha hecho entrega de las becas CRIS de Formación y Movilidad de @criscancer en el #DiaCienciaCRIS26 #CRISContraelCáncer

It’s a common misconception that life expectancy has increased only because fewer children die. Historical mortality records show that adults today also live much longer than adults in the past. It’s true that child mortality rates were much higher in the past, and their decline has greatly improved overall life expectancy. But in recent decades, improvements in survival at older ages have been even more important. The chart shows the period life expectancy in France for people of different ages. This measures how long someone at each of those ages would live, on average, if they experienced the death rates recorded in that year. As you can see, life expectancy in France has risen at every age. In 1816, someone who had reached the age of 10 could expect to live to 57. By 2023, this had increased to 84. For those aged 65, it rose from 76 in 1816 to 87 in 2023. The data for many other countries shows the same. This remarkable shift is the result of advances in medicine, public health, and living standards.

🎯 BULLSEYE trial: ¹⁷⁷Lu-PSMA-617 in oligometastatic hormone-sensitive #prostatecancer: @TheLancetOncol 📈 Median PFS: 25 months vs just 5 months for deferred ADT 💥 83% had ≥50% PSA drop (24% complete response!) ✅ Well tolerated — HRQoL maintained ⏳ ADT-free survival: 26 months Could this be a manner to delay hormone therapy? 🤔 @UrologyTimes @urotoday @renalandurology 🔗shorturl.at/sSBVk

New in the #RedJournal from @JablonskaPaola et al: A novel multimodal model to predict radiation necrosis risk in brain metastases treated with SRS/FSRT. The Necrosis Prediction Index (NPI) integrates baseline blood biomarkers (CXCL11, MUC-16) with PTV. tinyurl.com/rjjablonska

New decision analysis: For rectal cancer patients with complete response after chemoRT, choosing surgery over "Watch & Wait" costs ~9 QALYs - almost a decade of perfect health - lost to permanent toxicity (LARS, sexual dysfunction, stoma)

Exciting Update: TotalSegmentator supports segmentation of liver lesions on both CT and MR images. Free and easy to use. Great team effort by the University Hospital Basel Radiology team. paper: link.springer.com/article/10.100… code: github.com/wasserth/Total…

Among men with locally advanced prostate cancer, transdermal estradiol was noninferior to LHRH agonists for 3-year metastasis-free survival and led to a lower incidence of hot flashes but a higher incidence of gynecomastia. Full results of the STAMPEDE-1 and PATCH trials: nejm.org/doi/full/10.10…

SBRT is reshaping oligometastatic prostate cancer 🎯 It can delay systemic therapy & prolong disease control⏳ Congrats to all co-authors especially Macarena Teja & Miguel Ángel Berenguer💪 Honored to publish with @VedangMurthy & @GiuliaMarvaso84 ⭐ 🔗 mdpi.com/2075-1729/16/4…

In 1966, abortion was suddenly restricted for most women in Romania. In the decades that followed, maternal mortality increased, and by the 1980s, more than 80% of maternal deaths happened as a result of abortion complications. Banning abortions didn’t stop them; instead, many women were forced to move from safe to unsafe, illegal methods. It was also at a time when contraception was severely restricted, too. When abortion was relegalized, maternal deaths fell again. Romania’s sudden policy changes created a rare natural experiment: when abortion was legal, maternal deaths were low; when it was banned, they rose; and when it was legalized again, they fell. While this situation was fairly unusual and not comparable to most countries today, this mechanism still applies. It is estimated that around 40% of women in the world live in countries where abortion is either completely illegal or severely restricted. In countries with tight restrictions, three-quarters of abortions are deemed to be unsafe. As a result, around 23,000 women die from abortion complications every year.

@5_utr @yuanjamesrao @adornisch_MD @UCSDCancer Patients often say bladder filling is the hardest part of treatment. Causes stress. They fail to keep it full, despite great effort and sometimes discomfort. They over-hydrate and then have urinate even more frequently. And we don’t even know if there is a point to it.

@DrSpratticus I haven’t done a DRE in years. Only useful imo if you don’t have access to MRI (which applies to too much of the world still sadly). If you need to do a DRE to build trust with the patient, then I would suggest there may be better ways.

Exercise after a cancer diagnosis may improve survival. A pooled analysis of 17,141 cancer survivors across 6 cohorts shows that post-diagnosis physical activity is associated with lower cancer mortality. 🏃‍♂️ Even small amounts of activity helped. 📊 Key findings • Any activity vs none reduced cancer mortality in – Bladder cancer: HR 0.67 – Endometrial cancer: HR 0.62 – Lung cancer: HR 0.56 • Meeting activity guidelines (≥7.5 MET-h/week) further improved survival. • Doubling guidelines showed benefit in – Oral cancer – Rectal cancer 💡 Important insight Patients who were inactive before diagnosis but became active after diagnosis had lower mortality in lung and rectal cancers. 🎯 Clinical message Encouraging physical activity after cancer diagnosis may improve survival across multiple tumor types. Exercise is not just supportive care. It may be prognostic therapy. #OncoTwitter #CancerSurvivorship #ExerciseOncology #MedTwitter @OncoAlert @myESMO @ASCO

Rivers are alive. A 50-year sequence of Peru’s Ucayali River shows how a river constantly shifts its bed, reshapes landscapes and redraws maps. Rivers move, ecosystems respond and planning must learn to work with that movement rather than pretend landscapes stay fixed. Source: linkedin.com/posts/damien-d…

#EAU26 Congrats to the FASTRACK teams @_ShankarSiva. SBRT for RCC now has greater prospective data than all other ablative treatments and is a guideline supported SOC. Excited to continue to expand its use through the conduct of well designed clinical trials. Patients want a non-invasive option, but we must continue to generate these excellent results. @ASTRO_org @NCCN @NRGonc @ASCO

PRostate cancer guidelines 2026 update. Digital rectal exam NOW no more recommended for Asymptomatic men SO NO MORE FOR Screening Important for standing and for early diagnosis for SYMPTOMS only @Uroweb